Leerink Partners maintains Outperform on Alexion Pharmaceuticals (NASDAQ: ALXN) price target of $153.00.ANalyst Geoffrey Porges warns ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE